NCT04369729 Investigate the Mechanisms, Predictors, and Prevention of Persistent Post-Traumatic Headache Status COMPLETED Phase N/A
NCT04362748 Study of AMG 256 in Adult Subjects With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04330430 Neo-adjuvant T-VEC + Nivolumab Combination Therapy for Resectable Early Metastatic (stage IIIB/C/D-IV M1a) Melanoma with Injectable Disease Status COMPLETED Phase PHASE2
NCT04329325 Blinatumomab and Tyrosine Kinase Inhibitor Therapy in People With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04307576 A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Status RECRUITING Phase PHASE3
NCT04306471 Effect of Evolocumab in Patients With Critical Limb Ischemia (Evol-CLI) Status UNKNOWN Phase PHASE4
NCT04306081 Effect of Evolocumab in Functional Status and LDL Oxidation of Patients With Peripheral Arterial Disease Status UNKNOWN Phase PHASE4
NCT04303780 Study to Compare AMG 510 "Proposed INN Sotorasib" With Docetaxel in Non Small Cell Lung Cancer (NSCLC) (CodeBreak 200). Status COMPLETED Phase PHASE3
NCT04293094 Study of AMG 650 in Adult Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT04292275 Heart Failure Study to Evaluate Vital Signs and Overcome Low Use of Guideline-Directed Therapy by Remote Monitoring Status TERMINATED Phase NA
NCT04287855 Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone With Carfilzomib in Relapsed or Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04270760 Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction - DOSE Finding Study Status COMPLETED Phase PHASE2
NCT04270747 A Study to Understand Effectiveness and Safety of ABP 938 Compared to Aflibercept (Eylea®) in Patients Suffering With Neovascular Age-related Macular Degeneration [Neovascular (Wet) AMD] Status COMPLETED Phase PHASE3
NCT04268498 A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04265755 Biomarker and Genetic Predictors of Erenumab Treatment Response Status COMPLETED Phase PHASE4
NCT04263480 Efficacy and Safety of Carfilzomib in Combination With Ibrutinib vs Ibrutinib in Waldenström's Macroglobulinemia Status ACTIVE_NOT_RECRUITING Phase PHASE2